(Erstwhile UTI Pharma & Healthcare Fund) Table of Contents The Investment objective of the Scheme is capital appreciation through investments in equities and equity related instruments of the Pharma & Healthcare sectors. UTI Healthcare Fund is a Equity - Sectoral fund launched on 28 Jun 99. It is a fund with High risk and has given a Below is the key information for UTI Healthcare Fund Returns up to 1 year are on Historical performance (Yearly) on absolute basis UTI Healthcare Fund - G
Scheme Objective
CAGR
return of 15.1% since its launch. Ranked 40 in Sectoral
category. Return for 2024 was 42.9% , 2023 was 38.2% and 2022 was -12.3% . NAV as on 18 Jul 25 ₹294.987 ↓ -1.62 (-0.54 %) Net Assets (AUM) as on 31 May 2025 ₹1,062 Cr. Launch Date 28 Jun 1999 Category Equity - Sectoral Rating ☆ Type Open Ended Fund Risk High AMC UTI Asset Management Company Ltd Alpha Ratio 0.87 Expense Ratio 2.38 % Sharpe Ratio 0.833 Information Ratio -0.11 Benchmark Not Available Min Investment ₹5,000 Min SIP Investment ₹500 Exit Load 0-1 Years (1%),1 Years and above(NIL) NAV Price Chart
Returns
Annual Compounded Returns
absolute basis
& more than 1 year are on CAGR (Compound Annual Growth Rate)
basis. as on 18 Jul 25 Duration Returns 1 Month 5% 3 Month 10.1% 6 Month 5.9% 1 Year 18.5% 3 Year 26.3% 5 Year 21.8% 10 Year 15 Year Since launch 15.1% Historical Annual Returns
Year Returns 2024 42.9% 2023 38.2% 2022 -12.3% 2021 19.1% 2020 67.4% 2019 1.2% 2018 -7.5% 2017 6.2% 2016 -9.7% Growth of 10k Over Years
Date Value 30 Jun 20 ₹10,000 30 Jun 21 ₹15,774 30 Jun 22 ₹13,373 30 Jun 23 ₹15,783 30 Jun 24 ₹22,500 30 Jun 25 ₹27,347 Asset Allocation
Asset Class Value Cash 2.67% Equity 97.33% Sector Allocation
Sector Value Health Care 96.34% Basic Materials 0.99% Top Securities Holdings / Portfolio
Holdings/Securities
Name Global Industry Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Oct 06 | SUNPHARMADrug Manufacturers - Specialty & Generic 10% ₹111 Cr 661,016
↓ -11,873 Cipla Ltd (Healthcare)
Equity, Since 31 Jan 03 | CIPLADrug Manufacturers - Specialty & Generic 6% ₹59 Cr 400,000 Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 28 Feb 18 | DRREDDYDrug Manufacturers - Specialty & Generic 5% ₹50 Cr 396,000 Procter & Gamble Health Ltd (Healthcare)
Equity, Since 31 Dec 20 | PGHLDrug Manufacturers - Specialty & Generic 4% ₹46 Cr 80,283
↑ 520 Ajanta Pharma Ltd (Healthcare)
Equity, Since 31 Jul 17 | AJANTPHARMDrug Manufacturers - Specialty & Generic 4% ₹43 Cr 172,829 Glenmark Pharmaceuticals Ltd (Healthcare)
Equity, Since 31 Mar 24 | GLENMARKDrug Manufacturers - Specialty & Generic 4% ₹40 Cr 275,250 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 30 Apr 21 | APOLLOHOSPMedical Care Facilities 4% ₹39 Cr 56,271 Divi's Laboratories Ltd (Healthcare)
Equity, Since 30 Sep 17 | DIVISLABDrug Manufacturers - Specialty & Generic 3% ₹37 Cr 56,000 Fortis Healthcare Ltd (Healthcare)
Equity, Since 31 Dec 20 | FORTISMedical Care Facilities 3% ₹33 Cr 465,000 Eris Lifesciences Ltd Registered Shs (Healthcare)
Equity, Since 31 Mar 19 | ERISDrug Manufacturers - Specialty & Generic 3% ₹32 Cr 204,451
↓ -8,479
Talk to our investment specialistFund Managers
Name Since Tenure Kamal Gada 2 May 22 3.08 Yr. Custodians
Company Address Axis Bank Ltd null Deutsche Bank AG MUMBAI Deitsche bank,Kodak House Stock Holding Corporation of India Mittal Court, ‘B’ Wing,,Nariman Point Registrar & Transfer Agent
KFin Technologies Ltd Address 138 -Suyesh Solitaire, Nr. Podar International School,Kudasan, Gandhinagar, Gujarat FAX N.A Email N.A Administrator Companies
Company Address UTI Asset Management Co Ltd PMS Division, UTI - Tower, “Gn” Block, Bandra Kurla Complex, Mumbai- 400051 Auditors
Company Address S. R. BATLIBOI & Co Express Tower, 6th Floor,Nariman Point,Mumbai All Plan & Options
Fund and Plan NAV 6 Month 1 Year 3 Year 5 Year UTI Healthcare Fund
Growth ₹294.987
↓ -1.62 5.88 % 18.5 % 26.32 % 21.76 % UTI Healthcare Fund
Normal Dividend, Payout ₹227.984
↓ -1.25 5.88 % 18.5 % 26.32 % 21.76 % UTI Healthcare Fund
Normal Dividend, Reinvestment ₹227.984
↓ -1.25 5.88 % 18.5 % 26.32 % 21.76 % Data as on 18 Jul 25